Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Neubauer

Showing results (481-490 of 554) with videos related to

Pageof 56
Sort By:
Oncogene|September 26, 2018
Cytoplasmic dynein regulates the subcellular localization of sphingosine kinase 2 to elicit tumor-suppressive functions in glioblastomaHeidi A Neubauer, Melinda N Tea, Julia R Zebol, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 16, 2003
Evidence of a graft-versus-leukemia effect in chronic lymphocytic leukemia after reduced-intensity conditioning and allogeneic stem-cell transplantation: the Cooperative German Transplant Study GroupJ Schetelig, C Thiede, M Bornhauser, et al.
Epilepsia|July 5, 2014
Analysis of ELP4, SRPX2, and interacting genes in typical and atypical rolandic epilepsyEva M Reinthaler, Dennis Lal, Wiktor Jurkowski, et al.
European Journal of Cancer (Oxford, England : 1990)|October 22, 2017
Long-term survival of sorafenib-treated FLT3-ITD-positive acute myeloid leukaemia patients relapsing after allogeneic stem cell transplantationS K Metzelder, T Schroeder, M Lübbert, et al.
Epilepsia|February 23, 2016
Predictors of and attitudes toward counseling about SUDEP and other epilepsy risk factors among Austrian, German, and Swiss neurologists and neuropediatriciansAdam Strzelczyk, Gerda Zschebek, Sebastian Bauer, et al.
Pharmaceuticals (Basel, Switzerland)|November 10, 2022
High Efficacy and Drug Synergy of HDAC6-Selective Inhibitor NN-429 in Natural Killer (NK)/T-Cell LymphomaHarsimran Kaur Garcha, Nabanita Nawar, Helena Sorger, et al.
Leukemia|April 15, 2025
Dual STAT3/STAT5 inhibition as a novel treatment strategy in T-prolymphocytic leukemiaAnnika Dechow, Sanna Timonen, Aleksandr Ianevski, et al.
Gut|December 14, 2005
Strong BCL10 nuclear expression identifies gastric MALT lymphomas that do not respond to H pylori eradicationH Ye, L Gong, H Liu, et al.
Journal of Oncology Practice|November 2, 2011
Creating a process to standardize regimen order sets within an electronic health recordLeslie T Busby, Sheetal Sheth, Jody Garey, et al.
Journal of the Advanced Practitioner in Oncology|January 13, 2025
Impact of an Oncology Clinical Pharmacist Intervention on Clinical Trial Enrollment in The US Oncology Network's MYLUNG ConsortiumElizabeth Koselke, Lisa C Kaspin-Powell, Shannon Hough, et al.
Pageof 56

Showing results (481-490 of 554) with videos related to

Sort By:
Pageof 56
Oncogene|September 26, 2018
Cytoplasmic dynein regulates the subcellular localization of sphingosine kinase 2 to elicit tumor-suppressive functions in glioblastomaHeidi A Neubauer, Melinda N Tea, Julia R Zebol, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 16, 2003
Evidence of a graft-versus-leukemia effect in chronic lymphocytic leukemia after reduced-intensity conditioning and allogeneic stem-cell transplantation: the Cooperative German Transplant Study GroupJ Schetelig, C Thiede, M Bornhauser, et al.
Epilepsia|July 5, 2014
Analysis of ELP4, SRPX2, and interacting genes in typical and atypical rolandic epilepsyEva M Reinthaler, Dennis Lal, Wiktor Jurkowski, et al.
European Journal of Cancer (Oxford, England : 1990)|October 22, 2017
Long-term survival of sorafenib-treated FLT3-ITD-positive acute myeloid leukaemia patients relapsing after allogeneic stem cell transplantationS K Metzelder, T Schroeder, M Lübbert, et al.
Epilepsia|February 23, 2016
Predictors of and attitudes toward counseling about SUDEP and other epilepsy risk factors among Austrian, German, and Swiss neurologists and neuropediatriciansAdam Strzelczyk, Gerda Zschebek, Sebastian Bauer, et al.
Pharmaceuticals (Basel, Switzerland)|November 10, 2022
High Efficacy and Drug Synergy of HDAC6-Selective Inhibitor NN-429 in Natural Killer (NK)/T-Cell LymphomaHarsimran Kaur Garcha, Nabanita Nawar, Helena Sorger, et al.
Leukemia|April 15, 2025
Dual STAT3/STAT5 inhibition as a novel treatment strategy in T-prolymphocytic leukemiaAnnika Dechow, Sanna Timonen, Aleksandr Ianevski, et al.
Gut|December 14, 2005
Strong BCL10 nuclear expression identifies gastric MALT lymphomas that do not respond to H pylori eradicationH Ye, L Gong, H Liu, et al.
Journal of Oncology Practice|November 2, 2011
Creating a process to standardize regimen order sets within an electronic health recordLeslie T Busby, Sheetal Sheth, Jody Garey, et al.
Journal of the Advanced Practitioner in Oncology|January 13, 2025
Impact of an Oncology Clinical Pharmacist Intervention on Clinical Trial Enrollment in The US Oncology Network's MYLUNG ConsortiumElizabeth Koselke, Lisa C Kaspin-Powell, Shannon Hough, et al.
Pageof 56